Stryker Corporation
Location
Michigan
Founded
1941-02-28
Website
Risk Signals
3741 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Orthopedic, Prosthetic, and Surgical Appliances and Supplies), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Stryker Corporation
Live alerts from global media, monitored by Business Radar
2025-05-10 (marketbeat.com)
Rep. Jefferson Shreve Sells HEICO Co. (NYSE:HEI.A) Stock
Representative Jefferson Shreve (R-Indiana) recently sold shares of HEICO Co. (NYSE:HEI.A). In a filing disclosed on May 08th, the Representative disclosed that they had sold between $15,001 and $50,000 in HEICO stock on April 17th. The trade occurred in the Representative's "CRT - STANDARD UNIT TR
Read more2025-05-06 (beckersspine.com)
Stryker vs. Zimmer Biomet vs. J&J in Q1 2025: How 3 orthopedic companies compare - Becker's Spine Review
Stryker, Johnson & Johnson and Zimmer Biomet posted their first-quarter financial results for 2025 and data on their spine orthopedic sales. Here is how they compare: Stryker Total sales: $5.9 billion (+11.9%) Orthopedics: $2.3 billion (+9.7%) Hips: $443 million (+12.7%) Knees: $639 million (+8.7%) Spine: $166 million (-2.9%) Net earnings: $654 million Zimmer Biomet Total […]
Read more
2025-05-05 (investing.com)
UBS raises its share price target to $421, previously $405 Provider Investing.com
Investing.com — UBS analyst Danielle Antalffy raised the target price of Stryker stock to $421.00 from its previous $405.00, while maintaining a "neutral" rating on the stock. The $143.66 billion medical technology giant is currently trading close to its 52-week high of $406.19. According to InvestingPro analysis, the stock appears to be overvalued at the current level, with a price-to-earnings ratio of 50.13. The adjustment comes after Stryker's recent performance, with sales and earnings per share (EPS) exceeding expectations. In addition, the company's guidance on organic sales growth in 2025 also exceeded market consensus, and is now expected to grow 8.5% to 9.5% year-on-year, higher than the 8% to 9% forecast earlier.
Read more
2025-04-22 (investing.com)
TD Cowen maintains Stryker stock Buy rating, $435 target By
TD Cowen maintains Stryker stock Buy rating, $435 target
Read more2025-03-31 (investors.com)
Stocks With Rising Relative Strength: Stryker | Investor's Business Daily
A Relative Strength Rating upgrade for Stryker shows improving technical performance. Will it continue?
Read more
2025-03-26 (nasdaq.com)
S&P 500 Movers: SYK, CTAS |
In early trading on Wednesday, shares of Cintas topped the list of the day's best performing components of the S&P 500 index, trading up 9.3%. Year to date, Cintas registers a 15.8% gain.And the worst performing S&P 500 component thus far on the day is Stryker, tradi
Read more2025-03-08 (capitalizethings.com)
Are Small Cap Stocks A Good Investment? Pros And Cons
Investing in small-cap stocks involves purchasing shares of companies with smaller market capitalizations, typically ranging from $300 million to $2 billion,
Read more2025-02-10 (marketbeat.com)
Quilter Plc Sells 4,736 Shares of Stryker Co. (NYSE:SYK)
Quilter Plc trimmed its position in shares of Stryker Co. (NYSE:SYK - Free Report) by 4.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 111,676 shares of the medical technology company's stock after selli
Read more2025-01-29 (marketbeat.com)
Stryker (NYSE:SYK) Price Target Raised to $435.00
Royal Bank of Canada increased their target price on Stryker from $425.00 to $435.00 and gave the company an "outperform" rating in a research note on Wednesday.
Read more2025-01-29 (investors.com)
Stryker Stock Undercuts Breakout On Sales Deal, Despite Quarterly Beat | Investor's Business Daily
Stryker stock dipped late Tuesday after the medtech company beat forecasts, but announced its plan to divest the U.S. spinal business.
Read more2025-01-25 (trefis.com)
Why Stryker Stock Moved: SYK Stock Has Gained 65% Since 2022 Fiscal End, Primarily Due To Favorable Change In Price To Sales Multiple (P/S) |
This interactive model has a limit on the number of drivers that can be modified in a single scenario. When the limit is reached those drivers not yet modified become disabled for modification.
Read more
2025-01-25 (aktiencheck.de)
Stryker Stock: Burgeoning Market Opportunities () | .de
Stryker stock: flourishing market opportunities () | aktiencheck.de
Read more